248 related articles for article (PubMed ID: 7526275)
1. Antibodies to hepatitis C virus (HCV) in chronic renal failure (CRF) patients on conservative therapy: prevalence, risk factors and relationship to liver disease.
Fabrizi F; Marcelli D; Bacchini G; Guarnori I; Erba G; Locatelli F
Nephrol Dial Transplant; 1994; 9(7):780-4. PubMed ID: 7526275
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of hepatitis C virus antibodies in hemodialysis patients and dialysis staff.
Fujiyama S; Kawano S; Sato S; Tanaka M; Goto M; Taura Y; Sato T; Kawahara T; Mizuno K
Hepatogastroenterology; 1992 Apr; 39(2):161-5. PubMed ID: 1378811
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of occult hepatitis B and hepatitis C virus infections in Turkish hemodialysis patients.
Yakaryilmaz F; Gurbuz OA; Guliter S; Mert A; Songur Y; Karakan T; Keles H
Ren Fail; 2006; 28(8):729-35. PubMed ID: 17162434
[TBL] [Abstract][Full Text] [Related]
4. Decreased serum aminotransferase activity in patients with chronic renal failure: impact on the detection of viral hepatitis.
Fabrizi F; Lunghi G; Finazzi S; Colucci P; Pagano A; Ponticelli C; Locatelli F
Am J Kidney Dis; 2001 Nov; 38(5):1009-15. PubMed ID: 11684554
[TBL] [Abstract][Full Text] [Related]
5. Antibodies to hepatitis C virus: a cross-sectional study in patients attending a trauma unit or admitted to hospital for elective surgery.
García-Bengoechea M; Emparanza JI; Sarriugarte A; Cortés A; Vega JL; González F; Arenas JI
Eur J Gastroenterol Hepatol; 1995 Mar; 7(3):237-41. PubMed ID: 7538032
[TBL] [Abstract][Full Text] [Related]
6. [Infection of hepatitis C virus in patients with chronic renal failure undergoing hemodialysis therapy and staff members].
Miyasaka M
Nihon Jinzo Gakkai Shi; 1991 Oct; 33(10):989-99. PubMed ID: 1722830
[TBL] [Abstract][Full Text] [Related]
7. Antibodies to hepatitis C virus by second generation test in hemodialyzed patients.
Chauveau P; Courouce AM; Lemarec N; Naret C; Poignet JL; Girault A; Ramdame M; Delons S
Kidney Int Suppl; 1993 Jun; 41():S149-52. PubMed ID: 7686591
[TBL] [Abstract][Full Text] [Related]
8. [Prevalence of anti hepatitis C antibodies in patients with chronic renal failure receiving conservative therapy].
de Los Ríos R; Bussalleu A; Hurtado A; Valdivia J; Huerta Mercado J; Battilana C; Pala M; Pinto JL; Piscoya A; Cedrón H
Rev Gastroenterol Peru; 2006; 26(3):265-70. PubMed ID: 17053822
[TBL] [Abstract][Full Text] [Related]
9. Detection of antibodies to HCV in haemodialysis patients using two second generation ELISA tests.
Dentico P; Volpe A; Buongiorno R; Fiore G; Carbone M; Manno C; Pastore G; Schiraldi O
Ital J Gastroenterol; 1993 Jan; 25(1):19-22. PubMed ID: 7679012
[TBL] [Abstract][Full Text] [Related]
10. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
[TBL] [Abstract][Full Text] [Related]
11. Seropositivity to hepatitis C virus in Tunisian haemodialysis patients.
Jemni S; Ikbel K; Kortas M; Mahjoub J; Ghachem L; Bidet JM; Boukef K
Nouv Rev Fr Hematol (1978); 1994 Oct; 36(5):349-51. PubMed ID: 7534398
[TBL] [Abstract][Full Text] [Related]
12. Low prevalence of anti-hepatitis C virus antibodies in female hemodialysis patients without blood transfusion: a multicenter analysis.
Nakayama E; Liu JH; Akiba T; Marumo F; Sato C
J Med Virol; 1996 Mar; 48(3):284-8. PubMed ID: 8801291
[TBL] [Abstract][Full Text] [Related]
13. Prevalence, risk factors, and genotype distribution of hepatitis C virus infection in the general population: a community-based survey in southern Italy.
Guadagnino V; Stroffolini T; Rapicetta M; Costantino A; Kondili LA; Menniti-Ippolito F; Caroleo B; Costa C; Griffo G; Loiacono L; Pisani V; Focà A; Piazza M
Hepatology; 1997 Oct; 26(4):1006-11. PubMed ID: 9328327
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis C virus infection in thalassemia patients undergoing allogeneic bone marrow transplantation.
Erer B; Angelucci E; Lucarelli G; Giardini C; Baronciani D; Galimberti M; Polchi P; Amadei G; Battistini L; Paolucci S
Bone Marrow Transplant; 1994 Sep; 14(3):369-72. PubMed ID: 7527690
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of antibodies to hepatitis C virus in patients on peritoneal dialysis--a multicenter study.
Gladziwa U; Schlipköter U; Lorbeer B; Cholmakow K; Roggendorf M; Sieberth HG
Clin Nephrol; 1993 Jul; 40(1):46-52. PubMed ID: 7689431
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of hepatitis C virus infection to alcoholics with cirrhosis in Korea.
Kwon SY; Ahn MS; Chang HJ
J Gastroenterol Hepatol; 2000 Nov; 15(11):1282-6. PubMed ID: 11129222
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C virus (HCV) infection in haemodialysed patients: HCV-RNA and anti-HCV antibodies (third-generation assays).
Couroucé AM; Bouchardeau F; Chauveau P; Le Marrec N; Girault A; Zins B; Naret C; Poignet JL
Nephrol Dial Transplant; 1995; 10(2):234-9. PubMed ID: 7538650
[TBL] [Abstract][Full Text] [Related]
18. Changes in prevalence of anti-HCV antibodies associated with preventive measures among hemodialysis patients and dialysis staff.
Fujiyama S; Kawano S; Sato S; Shimada H; Matsushita K; Ikezaki N; Nakano T; Sato T
Hepatogastroenterology; 1995 Apr; 42(2):162-5. PubMed ID: 7545641
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C-related hepatocellular carcinoma. Prevalence and significance.
Resnick RH; Koff R
Arch Intern Med; 1993 Jul; 153(14):1672-7. PubMed ID: 7687423
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of hepatitis B and C viruses in pre-dialysis patients with chronic renal failure.
Salako BL; Ayodele OE; Kadiri S; Arije A
Afr J Med Med Sci; 2002 Dec; 31(4):311-4. PubMed ID: 15027769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]